| pubmed-article:17310820 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C0209738 | lld:lifeskim |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C0457454 | lld:lifeskim |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:17310820 | lifeskim:mentions | umls-concept:C1444662 | lld:lifeskim |
| pubmed-article:17310820 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17310820 | pubmed:dateCreated | 2007-2-21 | lld:pubmed |
| pubmed-article:17310820 | pubmed:abstractText | Lamivudine (3TC) therapy can cause the emergence of M1841/V. Previous studies suggest a higher fidelity of the mutant reverse transcriptase and lower replication capacity of the mutant virus. No data exist from clinical comparative studies evaluating the benefit of M1841/V in patients receiving combination antiretroviral therapy (cART). | lld:pubmed |
| pubmed-article:17310820 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17310820 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17310820 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17310820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17310820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17310820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17310820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17310820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17310820 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17310820 | pubmed:issn | 1359-6535 | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:GuoY EYE | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:PhillipsAndre... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:KatlamaChrist... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:YouleMikeM | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:HillAndrewA | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:LundgrenJens... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:DellamonicaPi... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:MathiesenLars... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:BruunJohan... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:GerstoftJanJ | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:ClumeckNathan... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:KjaerJesperJ | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:DragstedUlrik... | lld:pubmed |
| pubmed-article:17310820 | pubmed:author | pubmed-author:COLATE... | lld:pubmed |
| pubmed-article:17310820 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17310820 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:17310820 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17310820 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17310820 | pubmed:pagination | 761-70 | lld:pubmed |
| pubmed-article:17310820 | pubmed:dateRevised | 2009-6-26 | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:meshHeading | pubmed-meshheading:17310820... | lld:pubmed |
| pubmed-article:17310820 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17310820 | pubmed:articleTitle | A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial. | lld:pubmed |
| pubmed-article:17310820 | pubmed:affiliation | Copenhagen HIV Programme (CHIP), Hvidovre University Hospital, Copenhagen, Denmark. | lld:pubmed |
| pubmed-article:17310820 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17310820 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17310820 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17310820 | pubmed:publicationType | Clinical Trial, Phase IV | lld:pubmed |
